Advertisement

#Ocaliva

First Large Study Shows Liver Fibrosis Improvement in People with NASH

food with high fiber content for a healthy diet with fruit, vegetables, whole wheat bread, pasta, nuts, legumes, grains and cereals

How Is NAFLD/NASH Treated Today?

NAFLD/NASH Medication Pipeline

First Large Study Shows Liver Fibrosis Improvement in People with NASH

food with high fiber content for a healthy diet with fruit, vegetables, whole wheat bread, pasta, nuts, legumes, grains and cereals

How Is NAFLD/NASH Treated Today?

NAFLD/NASH Medication Pipeline

Intercept’s NASH Drug

A placebo-controlled study of obeticholic acid showed it improved liver fibrosis with no worsening of non-alcoholic steatohepatitis.

International Liver Congress Roundup

A quick overview of Hep Magazine’s reporting on the 53rd International Liver Congress in Vienna

What Is Primary Biliary Cholangitis?

Ocaliva

FDA Approves Ocaliva, New Drug for Primary Biliary Cirrhosis (PBC)

The FDA has approved Intercept Pharmaceuticals’ Ocaliva to treat primary biliary cholangitis, previously known as primary biliary cirrhosis.

Intercept NASH Drug OCA Gets FDA Fast-Track Status

The drug has been shown to help reduce markers of liver inflammation and fibrosis, as well as increase insulin sensitivity.

Advertisement